Given that tau loss of function in animal models does not replicate human clinical phenotypes, and genome-wide screens (GWAS) for disease-associated mutations only identify gain-of-function mutations in the tau-encoding gene, MAPT, toxic gain of function has been historically suggested as the cause of tauopathies (12). The gene discussed is MAPT; the disease is tauopathy.